Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 9/2016

07.09.2015 | Head and Neck

The importance of early diagnosis in patients with maxillary sinus carcinoma

verfasst von: Matthias Kreppel, Ali-Farid Safi, Martin Scheer, Hans-Joachim Nickenig, Joachim Zöller, Simon Preuss, Moritz Meyer, Daniel Rothamel, Timo Dreiseidler

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

There are two major challenges in the early diagnosis of maxillary sinus carcinoma: the maxillary sinus is not susceptible to direct inspection and palpation, and symptoms are uncharacteristic. The aim of this study was to assess the impact of the time interval between first symptoms noticed by the patient and the detection of the tumor on survival. 88 patients with maxillary sinus tumors were included in the retrospective study. Prognostic factors were identified through univariate analysis. Univariate analysis (p = 0.019) revealed a significant impact of the time interval from first symptom to diagnosis on overall survival. With increasing duration of the symptoms 5-year overall survival was reduced from 65 % for duration between 0 and 2 months to 24 % for duration of symptoms longer than 12 months. Furthermore, we found a significant association (p = 0.033) between local extension of the tumor and time interval from first symptom to diagnosis. Early diagnosis is often difficult because of uncharacteristic symptoms, which are identical with benign diseases of the maxillary sinus. The delay between the occurrence of the first symptom and diagnosis often makes a curative treatment impossible.
Literatur
1.
Zurück zum Zitat Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34(6):877–885CrossRefPubMed Turner JH, Reh DD (2012) Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 34(6):877–885CrossRefPubMed
2.
Zurück zum Zitat Robbins KT, Ferlito A, Silver CE et al (2011) Contemporary management of sinonasal cancer. Head Neck 33(9):1352–1365CrossRefPubMed Robbins KT, Ferlito A, Silver CE et al (2011) Contemporary management of sinonasal cancer. Head Neck 33(9):1352–1365CrossRefPubMed
3.
Zurück zum Zitat Takes RP, Ferlito A, Silver CE et al (2014) The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus. Eur Arch Otorhinolaryngol 271(5):899–904CrossRefPubMed Takes RP, Ferlito A, Silver CE et al (2014) The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus. Eur Arch Otorhinolaryngol 271(5):899–904CrossRefPubMed
4.
Zurück zum Zitat Bhattacharyya N (2002) Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 128(9):1079–1083CrossRefPubMed Bhattacharyya N (2002) Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 128(9):1079–1083CrossRefPubMed
5.
Zurück zum Zitat Khademi B, Moradi A, Hoseini S et al (2009) Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 13(4):191–199CrossRefPubMed Khademi B, Moradi A, Hoseini S et al (2009) Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 13(4):191–199CrossRefPubMed
6.
Zurück zum Zitat Dulguerov P, Jacobsen MS, Allal AS et al (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92(12):3012–3029CrossRefPubMed Dulguerov P, Jacobsen MS, Allal AS et al (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 92(12):3012–3029CrossRefPubMed
7.
Zurück zum Zitat Bhattacharyya N (2003) Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 61(9):1016–1021CrossRefPubMed Bhattacharyya N (2003) Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 61(9):1016–1021CrossRefPubMed
8.
Zurück zum Zitat Paulino AC, Marks JE, Bricker P et al (1998) Results of treatment of patients with maxillary sinus carcinoma. Cancer 83(3):457–465CrossRefPubMed Paulino AC, Marks JE, Bricker P et al (1998) Results of treatment of patients with maxillary sinus carcinoma. Cancer 83(3):457–465CrossRefPubMed
9.
Zurück zum Zitat Tiwari R, Hardillo JA, Mehta D et al (2000) Squamous cell carcinoma of maxillary sinus. Head Neck 22(2):164–169CrossRefPubMed Tiwari R, Hardillo JA, Mehta D et al (2000) Squamous cell carcinoma of maxillary sinus. Head Neck 22(2):164–169CrossRefPubMed
10.
Zurück zum Zitat Camp S, Van Gerven L, Poorten VV et al (2015) Long-term follow-up of 123 patients with adenocarcinoma of the sinonasal tract treated with endoscopic resection and postoperative radiation therapy. Head Neck. doi:10.1002/hed.23900 PubMed Camp S, Van Gerven L, Poorten VV et al (2015) Long-term follow-up of 123 patients with adenocarcinoma of the sinonasal tract treated with endoscopic resection and postoperative radiation therapy. Head Neck. doi:10.​1002/​hed.​23900 PubMed
11.
Zurück zum Zitat Carrillo JF, Guemes A, Ramirez-Ortega MC et al (2005) Prognostic factors in maxillary sinus and nasal cavity carcinoma. Eur J Surg Oncol 31(10):1206–1212CrossRefPubMed Carrillo JF, Guemes A, Ramirez-Ortega MC et al (2005) Prognostic factors in maxillary sinus and nasal cavity carcinoma. Eur J Surg Oncol 31(10):1206–1212CrossRefPubMed
12.
Zurück zum Zitat Myers LL, Nussenbaum B, Bradford CR et al (2002) Paranasal sinus malignancies: an 18-year single institution experience. The Laryngoscope 112(11):1964–1969CrossRefPubMed Myers LL, Nussenbaum B, Bradford CR et al (2002) Paranasal sinus malignancies: an 18-year single institution experience. The Laryngoscope 112(11):1964–1969CrossRefPubMed
13.
Zurück zum Zitat Carrau RL, Myers EM, Johnson JT (1992) Paranasal sinus carcinoma–diagnosis, treatment, and prognosis. Oncology (Williston Park) 6(1):43–50 (discussion 55–6) Carrau RL, Myers EM, Johnson JT (1992) Paranasal sinus carcinoma–diagnosis, treatment, and prognosis. Oncology (Williston Park) 6(1):43–50 (discussion 55–6)
14.
Zurück zum Zitat Norlander T, Frödin JE, Silfverswärd C et al (2003) Decreasing incidence of malignant tumors of the paranasal sinuses in Sweden. An analysis of 141 consecutive cases at Karolinska Hospital from 1960 to 1980. Ann Otol Rhinol Laryngol 112(3):236–241CrossRefPubMed Norlander T, Frödin JE, Silfverswärd C et al (2003) Decreasing incidence of malignant tumors of the paranasal sinuses in Sweden. An analysis of 141 consecutive cases at Karolinska Hospital from 1960 to 1980. Ann Otol Rhinol Laryngol 112(3):236–241CrossRefPubMed
15.
Zurück zum Zitat Al-Mamgani A, van Rooij P, Mehilal R et al (2013) Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol 270(1):293–299CrossRefPubMed Al-Mamgani A, van Rooij P, Mehilal R et al (2013) Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol 270(1):293–299CrossRefPubMed
16.
Zurück zum Zitat Katz TS, Mendenhall WM, Morris CG et al (2002) Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 24(9):821–829CrossRefPubMed Katz TS, Mendenhall WM, Morris CG et al (2002) Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 24(9):821–829CrossRefPubMed
17.
Zurück zum Zitat Suarez C, Rodrigo JP, Rinaldo A et al (2010) Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol 267(12):1811–1824CrossRefPubMedPubMedCentral Suarez C, Rodrigo JP, Rinaldo A et al (2010) Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol 267(12):1811–1824CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Guntinas-Lichius O, Kreppel MP, Stuetzer H et al (2007) Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 33(2):222–228CrossRefPubMed Guntinas-Lichius O, Kreppel MP, Stuetzer H et al (2007) Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 33(2):222–228CrossRefPubMed
19.
Zurück zum Zitat Kirwan JM, Tincello DG, Herod JJ et al (2002) Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ 324(7330):148–151CrossRefPubMedPubMedCentral Kirwan JM, Tincello DG, Herod JJ et al (2002) Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ 324(7330):148–151CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Rupassara KS, Ponnusamy S, Withanage N et al (2006) A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis 8(5):423–429CrossRefPubMed Rupassara KS, Ponnusamy S, Withanage N et al (2006) A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis. Colorectal Dis 8(5):423–429CrossRefPubMed
21.
Zurück zum Zitat Sainsbury R, Johnston C, Haward B (1999) Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 353(9159):1132–1135CrossRefPubMed Sainsbury R, Johnston C, Haward B (1999) Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 353(9159):1132–1135CrossRefPubMed
22.
Zurück zum Zitat Wikborn C, Pettersson F, Moberg PJ (1996) Delay in diagnosis of epithelial ovarian cancer. Int J Gynaecol Obstet 52(3):263–267CrossRefPubMed Wikborn C, Pettersson F, Moberg PJ (1996) Delay in diagnosis of epithelial ovarian cancer. Int J Gynaecol Obstet 52(3):263–267CrossRefPubMed
23.
Zurück zum Zitat Desjardins D, Huret C, Dalba C et al (2009) Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. J Gene Med 11(4):313–325CrossRefPubMed Desjardins D, Huret C, Dalba C et al (2009) Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. J Gene Med 11(4):313–325CrossRefPubMed
24.
Zurück zum Zitat Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef
25.
Zurück zum Zitat Waldron JN, O’Sullivan B, Gullane P et al (2000) Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 57(2):167–173CrossRefPubMed Waldron JN, O’Sullivan B, Gullane P et al (2000) Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 57(2):167–173CrossRefPubMed
26.
Zurück zum Zitat Kreppel M, Amir Manawi NN, Scheer M et al (2014) Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, seventh edition, for cancer of the maxillary sinus. Head Neck 37(3):400–406CrossRefPubMed Kreppel M, Amir Manawi NN, Scheer M et al (2014) Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, seventh edition, for cancer of the maxillary sinus. Head Neck 37(3):400–406CrossRefPubMed
27.
Zurück zum Zitat Shah JP, Kraus DH, Arbit E et al (1992) Craniofacial resection for tumors involving the anterior skull base. Otolaryngol Head Neck Surg 106(4):387–393PubMed Shah JP, Kraus DH, Arbit E et al (1992) Craniofacial resection for tumors involving the anterior skull base. Otolaryngol Head Neck Surg 106(4):387–393PubMed
28.
Zurück zum Zitat Shah JP, Kraus DH, Bilsky MH et al (1997) Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 123(12):1312–1317CrossRefPubMed Shah JP, Kraus DH, Bilsky MH et al (1997) Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 123(12):1312–1317CrossRefPubMed
29.
Zurück zum Zitat Suarez C, Llorente JL, Fernandez De Leon R et al (2004) Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 26(2):136–144CrossRefPubMed Suarez C, Llorente JL, Fernandez De Leon R et al (2004) Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 26(2):136–144CrossRefPubMed
30.
Zurück zum Zitat Sisson GA Sr, Toriumi DM, Atiyah RA (1989) Paranasal sinus malignancy: a comprehensive update. Laryngoscope 99(2):143–150CrossRefPubMed Sisson GA Sr, Toriumi DM, Atiyah RA (1989) Paranasal sinus malignancy: a comprehensive update. Laryngoscope 99(2):143–150CrossRefPubMed
31.
Zurück zum Zitat Robin PE, Powell DJ, Stansbie JM (1979) Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci 4(6):431–456CrossRefPubMed Robin PE, Powell DJ, Stansbie JM (1979) Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci 4(6):431–456CrossRefPubMed
32.
Zurück zum Zitat Blanco AI, Chao KS, Ozyigit G et al (2004) Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 59(1):51–58CrossRefPubMed Blanco AI, Chao KS, Ozyigit G et al (2004) Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 59(1):51–58CrossRefPubMed
33.
Zurück zum Zitat Miyaguchi M, Sakai S, Mori N et al (1990) Symptoms in patients with maxillary sinus carcinoma. J Laryngol Otol 104(7):557–559CrossRefPubMed Miyaguchi M, Sakai S, Mori N et al (1990) Symptoms in patients with maxillary sinus carcinoma. J Laryngol Otol 104(7):557–559CrossRefPubMed
34.
Zurück zum Zitat Dulguerov N, D’Souza A (2011) Update on treatment rationale and options for the ageing face. Curr Opin Otolaryngol Head Neck Surg 19(4):269–275CrossRefPubMed Dulguerov N, D’Souza A (2011) Update on treatment rationale and options for the ageing face. Curr Opin Otolaryngol Head Neck Surg 19(4):269–275CrossRefPubMed
35.
Zurück zum Zitat Dulguerov P, Allal AS (2006) Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg 14(2):67–72PubMed Dulguerov P, Allal AS (2006) Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg 14(2):67–72PubMed
Metadaten
Titel
The importance of early diagnosis in patients with maxillary sinus carcinoma
verfasst von
Matthias Kreppel
Ali-Farid Safi
Martin Scheer
Hans-Joachim Nickenig
Joachim Zöller
Simon Preuss
Moritz Meyer
Daniel Rothamel
Timo Dreiseidler
Publikationsdatum
07.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 9/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-015-3776-5

Weitere Artikel der Ausgabe 9/2016

European Archives of Oto-Rhino-Laryngology 9/2016 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.